BG
MED icon

BlackRock Group’s Medifast MED Stock Holding History

BlackRock Group’s Portfolio MED Stock Details MED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$1.74M Buy
41,882
+6,729
+19% +$271K ﹤0.01% 1863
2016
Q3 		$1.33M Buy
35,153
+14,577
+71% +$523K ﹤0.01% 1878
2016
Q2 		$684K Buy
20,576
+6,568
+47% +$212K ﹤0.01% 2146
2016
Q1 		$422K Buy
14,008
+5,142
+58% +$150K ﹤0.01% 2307
2015
Q4 		$270K Buy
8,866
+56
+0.6% +$1.67K ﹤0.01% 2433
2015
Q3 		$237K Sell
8,810
-1,501
-15% -$43.7K ﹤0.01% 2478
2015
Q2 		$333K Buy
10,311
+2,145
+26% +$68K ﹤0.01% 2415
2015
Q1 		$245K Buy
8,166
+1,190
+17% +$37.8K ﹤0.01% 2427
2014
Q4 		$234K Sell
6,976
-549
-7% -$17.1K ﹤0.01% 2472
2014
Q3 		$247K Sell
7,525
-319
-4% -$9.79K ﹤0.01% 2394
2014
Q2 		$239K Sell
7,844
-17,024
-68% -$531K ﹤0.01% 2416
2014
Q1 		$723K Sell
24,868
-1,680
-6% -$45K ﹤0.01% 2118
2013
Q4 		$694K Sell
26,548
-2,659
-9% -$68.1K ﹤0.01% 2122
2013
Q3 		$785K Buy
29,207
+6,109
+26% +$163K ﹤0.01% 2042
2013
Q2 		$595K Buy
+23,098
New +$607K ﹤0.01% 2007

Other funds holding MED

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $327M AUM 22.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock Group's MED Position: Q4 2016 in Review

BlackRock Group increased its Medifast (MED) stake by 19% in Q4 2016, buying an estimated $271K and bringing the position to 41,882 shares worth $1.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1863.

BlackRock Group first reported a position in MED in Q2 2013 and has held it in 15 quarters since. 162 funds tracked by Wall St. Rank hold MED as of Q4 2016.

  • BlackRock Group held 41,882 shares of Medifast worth $1.74M as of Q4 2016.
  • BlackRock Group bought 6,729 Medifast shares in Q4 2016, an estimated $271K.
  • Medifast made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1863 holding.
  • BlackRock Group first reported a position in Medifast in Q2 2013 and has held it in 15 quarters since.
  • 162 funds tracked by Wall St. Rank held Medifast as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.